iCAD to Present at the 12th Annual Needham Healthcare Conference Needham Healthcare Conference 2013 Business Wire NASHUA, N.H. -- April 24, 2013 iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today announced that the Company will be participating in the 12^th Annual Needham Healthcare Conference being held from April 30-May 1, 2013 at the Westin Grand Central Hotel in New York. Ken Ferry, iCAD’s President and CEO, will deliver a corporate overview on April 30^th at 12:10 p.m. A live webcast of Mr. Ferry’s presentation can be accessed by visiting the investors section of the Company’s website at www.icadmed.com. A replay of the webcast will be archived on the iCAD website for 90 days following the presentation. About iCAD, Inc. iCAD is a leading provider of advanced image analysis, workflow solutions and radiation therapies for the early identification and treatment of common cancers. iCAD offers a comprehensive range of high-performance, upgradeable CAD solutions for mammography and advanced image analysis and workflow solutions for Magnetic Resonance Imaging, for breast and prostate cancers and Computed Tomography for colorectal cancer. iCAD’s Xoft System, offers radiation treatment for early-stage breast cancer that can be administered in the form of intraoperative radiation therapy or accelerated partial breast irradiation. The Xoft System is also cleared for the treatment of non-melanoma skin cancer, cervical cancer and endometrial cancer. For more information, call 877-iCADnow, or visit www.icadmed.com. "Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: Certain statements contained in this News Release constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve a number of known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors include, but are not limited to, the Company’s ability to defend itself in litigation matters, the Company’s ability to identify a replacement for the Axxent FlexiShield Mini, the risks relating to the Company’s acquisition of Xoft including, the expected benefits of the acquisition may not be achieved in a timely manner, or at all; the Xoft business operations may not be successfully integrated with iCAD’s and iCAD may be unable to achieve the expected synergies, business and strategic objectives following the transaction, the risks of uncertainty of patent protection; the impact of supply and manufacturing constraints or difficulties; product market acceptance; possible technological obsolescence; increased competition; customer concentration; and other risks detailed in the Company’s filings with the Securities and Exchange Commission. The words “believe”, “demonstrate”, “intend”, “expect”, “estimate”, “anticipate”, “likely”, and similar expressions identify forward-looking statements. Readers are cautioned not to place undue reliance on those forward-looking statements, which speak only as of the date the statement was made. The Company is under no obligation to provide any updates to any information contained in this release. For additional disclosure regarding these and other risks faced by iCAD, please see the disclosure contained in our public filings with the Securities and Exchange Commission, available on the Investors section of our website at http://www.icadmed.com and on the SEC’s website at http://www.sec.gov. Contact: For iCAD Kevin Burns, 937-431-7967 firstname.lastname@example.org or For iCAD investor relations LHA Anne Marie Fields, 212-838-3777 x6604 email@example.com or For iCAD media inquiries Schwartz MSL Helen Shik, 781-684-0770 iCAD@schwartzmsl.com
iCAD to Present at the 12th Annual Needham Healthcare Conference
Press spacebar to pause and continue. Press esc to stop.